Celon Pharma

Celon Pharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celon Pharma (CLN.WA) as of Oct 22, 2026 is -56.76 M PLN. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 15.05 M PLN — a change of -477.21% (lower).

EBITDA

-56.76 MPLN

YoY

-477.21%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celon Pharma is 2025 -56.76 M PLN. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celon Pharma was 2024 15.05 M PLN. It decreases by -477.21% lower compared to the previous year.

The Celon Pharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
52.83 M PLN
Jan 1, 2019
27.52 M PLN
Jan 1, 2020
30.01 M PLN
Jan 1, 2021
27.81 M PLN
Jan 1, 2022
-25.67 M PLN
Jan 1, 2023
22.77 M PLN
Jan 1, 2024
15.05 M PLN
Jan 1, 2025
-56.76 M PLN
The Celon Pharma EBITDA history
YEAREBITDAYoY
-56.76 MPLN-477.21%
15.05 MPLN-33.92%
22.77 MPLN-188.73%
-25.67 MPLN-192.30%
27.81 MPLN-7.33%
30.01 MPLN+9.05%
27.52 MPLN-47.91%
52.83 MPLN+22.14%
43.25 MPLN-28.40%
60.41 MPLN+9.11%
55.37 MPLN+89.53%
29.21 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Celon Pharma Stock analysis

What does Celon Pharma do? Celon Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celon Pharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celon Pharma is -56.76 M PLN in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celon Pharma changed from 15.05 M PLN to -56.76 M PLN, representing a -477.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Celon Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Celon Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Celon Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Celon Pharma